0001213900-23-059274.txt : 20230724 0001213900-23-059274.hdr.sgml : 20230724 20230724172657 ACCESSION NUMBER: 0001213900-23-059274 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230723 FILED AS OF DATE: 20230724 DATE AS OF CHANGE: 20230724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lisicki Robert CENTRAL INDEX KEY: 0001779614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41596 FILM NUMBER: 231105914 MAIL ADDRESS: STREET 1: C/O ARENA PHARMACEUTICALS, INC. STREET 2: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cadrenal Therapeutics, Inc. CENTRAL INDEX KEY: 0001937993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880860746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 BUSINESS PHONE: 904-300-0701 MAIL ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 4 1 ownership.xml X0508 4 2023-07-23 0 0001937993 Cadrenal Therapeutics, Inc. CVKD 0001779614 Lisicki Robert C/O CADRENAL THERAPEUTICS, INC., 822 A1A NORTH, SUITE 306 PONTE VEDRA FL 32082 1 0 0 0 0 Stock options 1.20 2023-07-23 4 A 0 75000 0 A 2024-08-01 2033-07-23 Common Stock 75000 75000 D Consists of options to purchase 75,000 shares of common stock, which shall vest over a period of three years, with 1/3 vesting on August 1, 2024 and thereafter 1/36 on a monthly basis. /s/ Robert Lisicki 2023-07-24